Stay updated on Isatuximab for High-Risk Smoldering Myeloma Clinical Trial

Sign up to get notified when there's something new on the Isatuximab for High-Risk Smoldering Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Isatuximab for High-Risk Smoldering Myeloma Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The history entry now shows Revision: v3.6.3 in place of the previous v3.6.2, signaling a new version of the record page. This reflects an update to the page metadata and navigation history rather than substantive study content.
    Difference
    0.1%
    Check dated 2026-07-06T16:44:19.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The record history page shows a new revision tag (v3.6.2) replacing the previous v3.6.0, indicating a template or UI update to the history view. This does not alter any study data or listed records.
    Difference
    0.1%
    Check dated 2026-06-29T08:57:30.000Z thumbnail image
  4. Check
    31 days ago
    Change Detected
    Summary
    The recruitment status changes to no longer looking for participants. The page revision is updated to v3.6.0 (from v3.5.5).
    Difference
    0.2%
    Check dated 2026-06-15T06:00:52.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The page history now lists Revision: v3.5.5 replacing the previous v3.5.4, indicating a new revision of the record.
    Difference
    0.1%
    Check dated 2026-06-08T03:49:05.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    A new revision entry (v3.5.4) was added to the study record history, and the previous revision (v3.5.3) was removed from the history listing.
    Difference
    0.1%
    Check dated 2026-05-17T10:39:33.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    A minor ClinicalTrials.gov page revision/version update changes the displayed “Revision: v3.5.x” label from v3.5.2 to v3.5.3 without altering the trial record’s substantive details.
    Difference
    0.1%
    Check dated 2026-04-25T18:55:26.000Z thumbnail image

Stay in the know with updates to Isatuximab for High-Risk Smoldering Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Isatuximab for High-Risk Smoldering Myeloma Clinical Trial page.